The following table shows the list of Horizon 2020 projects developed by "F. HOFFMANN-LA ROCHE AG". Projects are ordered by starting date.
Click on table headers to rearrange data.
# | acronym | programme | role | EC contrib. | start | views |
---|---|---|---|---|---|---|
1 | EYE-RISK | H2020-EU.3.1.1. | participant | 0.00 | 2015-05-01 | 803 |
2 | BtRAIN | H2020-EU.1.3.1. | partner | 0.00 | 2015-09-01 | 923 |
3 | FRAGNET | H2020-EU.1.3.1. | partner | 0.00 | 2016-03-01 | 968 |
4 | EU-ToxRisk | H2020-EU.3.1.6. | participant | 0.00 | 2016-01-01 | 1246 |
5 | COSYN | H2020-EU.3.1.1. | participant | 0.00 | 2016-01-01 | 1247 |
6 | PSI-FELLOW-II-3i | H2020-EU.1.3.4. | partner | 0.00 | 2016-10-01 | 1093 |
7 | ADAPT-SMART | H2020-EU.3.1.7.13. | participant | 0.00 | 2015-07-01 | 746 |
8 | PRISM | H2020-EU.3.1.7. | participant | 0.00 | 2016-04-01 | 871 |
9 | PREFER | H2020-EU.3.1.7. | participant | 0.00 | 2016-10-01 | 692 |
10 | PHAGO | H2020-EU.3.1.7. | participant | 0.00 | 2016-11-01 | 964 |
11 | ROADMAP | H2020-EU.3.1.7. | participant | 0.00 | 2016-11-01 | 907 |
12 | DO-IT | H2020-EU.3.1.7. | participant | 0.00 | 2017-02-01 | 1072 |
13 | ITCC-P4 | H2020-EU.3.1.7. | participant | 0.00 | 2017-01-01 | 11500 |
14 | EQIPD | H2020-EU.3.1.7. | participant | 0.00 | 2017-10-01 | 851 |
15 | eTRANSAFE | H2020-EU.3.1.7. | participant | 0.00 | 2017-09-01 | 942 |
16 | MACUSTAR | H2020-EU.3.1.7. | participant | 0.00 | 2017-09-01 | 693 |
17 | PARADIGM | H2020-EU.3.1.7. | participant | 0.00 | 2018-03-01 | 628 |
18 | c4c | H2020-EU.3.1.7. | participant | 0.00 | 2018-05-01 | 419 |
19 | AIMS-2-TRIALS | H2020-EU.3.1.7. | participant | 0.00 | 2018-06-01 | 610 |
20 | StarT | H2020-EU.1.3.1. | partner | 0.00 | 2018-10-01 | 328 |
21 | NEURONET | H2020-EU.3.1.7. | participant | 0.00 | 2019-03-01 | 322 |
22 | TransBioLine | H2020-EU.3.1.7. | participant | 0.00 | 2019-02-01 | 367 |
23 | MIRIADE | H2020-EU.1.3.1. | participant | 281˙276.00 | 2019-11-01 | 315 |
24 | 3TR | H2020-EU.3.1.7. | participant | 0.00 | 2019-09-01 | 382 |
25 | Immune-Image | H2020-EU.3.1.7. | participant | 0.00 | 2019-10-01 | 432 |
26 | VIMS | H2020-EU.3.;H2020-EU.2.1. | participant | 421˙102.00 | 2019-11-01 | 334 |
27 | IDEA-FAST | H2020-EU.3.1.7. | participant | 0.00 | 2019-11-01 | 375 |
28 | PharmaLedger | H2020-EU.3.1.7. | participant | 0.00 | 2020-01-01 | 438 |
totale | 702˙378.00 |
This organization collaborated with partners in 29 countries.
Within the project EYE-RISK this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | PROR | PRO RETINA DEUTSCHLAND (OTH) |
participant | DE | AYOX | AYOXXA BIOSYSTEMS GMBH (PRC) |
participant | ES | BMF | FUNDACION BARCELONA MACULA FOUNDATION RESEARCH FOR VISION (REC) |
participant | FR | UB | UNIVERSITE DE BORDEAUX (HES) |
participant | UK | MEH | MOORFIELDS EYE HOSPITAL NHS FOUNDATION TRUST (REC) |
participant | ES | FPS | FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD (REC) |
participant | ES | CRG | FUNDACIO CENTRE DE REGULACIO GENOMICA (REC) |
participant | IE | NUID UCD | UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN (HES) |
participant | UK | UCL | UNIVERSITY COLLEGE LONDON (HES) |
participant | NL | EMC | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
coordinator | DE | EKUT | EBERHARD KARLS UNIVERSITAET TUEBINGEN (HES) |
participant | UK | QUB | THE QUEEN'S UNIVERSITY OF BELFAST (HES) |
participant | NL | Radboudumc | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
Within the project BtRAIN this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
partner | CH | Scitec-media GmbH (OTH) | |
participant | NL | STICHTING VUMC | STICHTING VUMC (REC) |
partner | US | USD | UNIVERSITY OF SAN DIEGO (HES) |
partner | DE | LVBT | LAVISION BIOTEC GMBH (PRC) |
participant | NL | STICHTING VU | STICHTING VU (HES) |
partner | NL | NCARDIA BV | NCARDIA BV (PRC) |
partner | IT | B4B | BRAINS FOR BRAIN FOUNDATION ONLUS (REC) |
participant | DE | GXP | GENXPRO GMBH (PRC) |
participant | HU | MTA SZBK | SZEGEDI BIOLOGIAI KUTATOKOZPONT (REC) |
participant | IT | IFOM | IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE (REC) |
partner | DE | TP21 | TP21 GMBH (PRC) |
participant | FR | CRIL-Artois | UNIVERSITE D'ARTOIS (HES) |
participant | UK | OU | THE OPEN UNIVERSITY (HES) |
participant | CH | EPFL | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (HES) |
coordinator | CH | UNIBERN | UNIVERSITAET BERN (HES) |
participant | DE | IAP | JOHANN WOLFGANG GOETHE-UNIVERSITATFRANKFURT AM MAIN (HES) |
participant | BE | ULB | UNIVERSITE LIBRE DE BRUXELLES (HES) |
participant | DE | UHEI | RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG (HES) |
partner | DE | MPG | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV (REC) |
Within the project FRAGNET this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
partner | NL | 24 Media Labs (PRC) | |
partner | UK | IOTA PHARMACEUTICALS LTD | IOTA Pharmaceuticals Ltd (PRC) |
participant | UK | Vernalis | VERNALIS (R&D) LIMITED (PRC) |
coordinator | NL | STICHTING VU | STICHTING VU (HES) |
participant | NL | ZoBio BV | ZOBIO BV (PRC) |
participant | SE | BEACTICA AB | BEACTICA THERAPEUTICS AB (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | HU | MTA TTK | TERMESZETTUDOMANYI KUTATOKOZPONT (HES) |
partner | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
partner | FR | Servier | INSTITUT DE RECHERCHES SERVIER (PRC) |
participant | UK | UY | UNIVERSITY OF YORK (HES) |
participant | ES | UB | UNIVERSITAT DE BARCELONA (HES) |
Within the project EU-ToxRisk this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | UK | NERC | UNITED KINGDOM RESEARCH AND INNOVATION (REC) |
participant | DK | DEPA | The Danish Environmental Protection Agency (PUB) |
participant | UK | OPF | OPEN PHACTS FOUNDATION LBG (REC) |
participant | BE | CE | COSMETICS EUROPE - THE PERSONAL CARE ASSOCIATION (OTH) |
participant | NL | VUA | STICHTING VU (HES) |
participant | CH | IS | INSPHERO AG (PRC) |
participant | DE | TissUse | TISSUSE GMBH (PRC) |
participant | CH | DC | EDELWEISS CONNECT GMBH (PRC) |
participant | ES | HULAFE | FUNDACION PARA LA INVESTIGACION DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA (REC) |
participant | UK | LHASA | LHASA LIMITED (REC) |
participant | UK | CRX | CYPROTEX DISCOVERY LIMITED (PRC) |
participant | US | JHSPH | JOHNS HOPKINS UNIVERSITY (HES) |
participant | DE | BAuA | BUNDESANSTALT FUER ARBEITSSCHUTZ UND ARBEITSMEDIZIN (PUB) |
participant | NL | BDS | BioDetection Systems B.V. (PRC) |
participant | DE | IFADO | FORSCHUNGSGESELLSCHAFT FUR ARBEITSPHYSIOLOGIE UND ARBEITSSCHUTZ E.V. (HES) |
participant | UK | SIMCYP | CERTARA UK LIMITED (PRC) |
participant | FR | L'OREAL | L'OREAL SA (PRC) |
participant | IT | IRFMN | ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI (REC) |
participant | FR | ARTTIC | ARTTIC (PRC) |
participant | DE | BASF | BASF SE (PRC) |
participant | AT | MUI | MEDIZINISCHE UNIVERSITAT INNSBRUCK (HES) |
participant | DE | UKON | UNIVERSITAT KONSTANZ (HES) |
participant | AT | UNIVIE | UNIVERSITAT WIEN (HES) |
participant | ES | UPF | UNIVERSIDAD POMPEU FABRA (HES) |
participant | UK | Unilever | UNILEVER U.K. CENTRAL RESOURCES LIMITED (PRC) |
participant | HU | BIOT | BIOTALENTUM TUDASFEJLESZTO KFT (PRC) |
participant | FR | INERIS | INSTITUT NATIONAL DE L ENVIRONNEMENT ET DES RISQUES INERIS (REC) |
participant | DE | CAATEU | STEINBEIS GMBH & CO. KG FUER TECHNOLOGIETRANSFER (PRC) |
coordinator | NL | U LEIDEN | UNIVERSITEIT LEIDEN (HES) |
participant | NL | UM | UNIVERSITEIT MAASTRICHT (HES) |
participant | SE | Swetox/KI | KAROLINSKA INSTITUTET (HES) |
participant | IT | ISS | ISTITUTO SUPERIORE DI SANITA (REC) |
participant | DE | Fraunhofer | FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (REC) |
participant | DE | UHEI | RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG (HES) |
participant | DE | EMBL | EUROPEAN MOLECULAR BIOLOGY LABORATORY (REC) |
participant | NL | TNO | NEDERLANDSE ORGANISATIE VOOR TOEGEPAST NATUURWETENSCHAPPELIJK ONDERZOEK TNO (REC) |
participant | UK | NC3Rs | MEDICAL RESEARCH COUNCIL (REC) |
participant | NL | LUMC | ACADEMISCH ZIEKENHUIS LEIDEN (HES) |
participant | DK | UCPH | KOBENHAVNS UNIVERSITET (HES) |
participant | BE | KU Leuven | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
Within the project COSYN this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | CEGAT GMBH | CEGAT GMBH (PRC) |
participant | NL | STICHTING VU | STICHTING VU (HES) |
participant | DE | L&B | LIFE AND BRAIN GMBH (PRC) |
participant | NL | VSOP | VERENIGING SAMENWERKENDE OUDER- EN PATIENTENORGANISATIES (PUB) |
participant | DK | CRD | REGION HOVEDSTADEN (PUB) |
participant | NL | Sylics | SYNAPTOLOGICS BV (PRC) |
participant | DE | UKB | UNIVERSITATSKLINIKUM BONN (HES) |
participant | DK | Lundbeck | H. LUNDBECK AS (PRC) |
coordinator | SE | KI | KAROLINSKA INSTITUTET (HES) |
participant | UK | CU | CARDIFF UNIVERSITY (HES) |
participant | DE | MPG | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV (REC) |
participant | FR | IP | INSTITUT PASTEUR (REC) |
participant | FI | UH | HELSINGIN YLIOPISTO (HES) |
Within the project PSI-FELLOW-II-3i this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
partner | CH | Ampegon AG (PRC) | |
partner | SE | LU | LUNDS UNIVERSITET (HES) |
partner | CH | SwissNeutronics AG (PRC) | |
partner | SE | ESS | EUROPEAN SPALLATION SOURCE ESS AB (REC) |
partner | CH | NOVARTIS | NOVARTIS INTERNATIONAL AG (PRC) |
partner | FR | SOLEIL | SYNCHROTRON SOLEIL SOCIETE CIVILE (PRC) |
partner | CH | ABB SUISSE SA ABB SWITZERLAND LTD | ABB SCHWEIZ AG (PRC) |
partner | IT | ELETTRA | ELETTRA - SINCROTRONE TRIESTE SCPA (REC) |
partner | CH | EMPA | EIDGENOSSISCHE MATERIALPRUFUNGS- UND FORSCHUNGSANSTALT (HES) |
partner | CH | BU | UNIVERSITAT BASEL (HES) |
partner | CH | IBMZ | IBM RESEARCH GMBH (PRC) |
partner | FR | ILL | INSTITUT MAX VON LAUE - PAUL LANGEVIN (REC) |
partner | CH | ETH Zürich | EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH (HES) |
partner | DE | DESY | STIFTUNG DEUTSCHES ELEKTRONEN-SYNCHROTRON DESY (REC) |
coordinator | CH | PSI | PAUL SCHERRER INSTITUT (REC) |
Within the project ADAPT-SMART this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | CH | SHIRE | SHIRE INTERNATIONAL GMBH (PRC) |
participant | UK | AbbVie | AbbVie Ltd (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | IT | AIFA | AGENZIA ITALIANA DEL FARMACO (PRC) |
participant | FR | Lysogene | LYSOGENE (PRC) |
participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
participant | UK | Astellas | ASTELLAS PHARMA EUROPE LTD (PRC) |
participant | NL | ZIN | ZORGINSTITUUT NEDERLAND (PUB) |
participant | FR | IPSEN | IPSEN INNOVATION SAS (PRC) |
participant | FR | HAS | HAUTE AUTORITE DE SANTE (PUB) |
participant | FR | EURORDIS | EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION (OTH) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
participant | US | BMS | BRISTOL-MYERS SQUIBB COMPANY CORP (PRC) |
participant | BE | Amgen | AMGEN (PRC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | UK | EMA | THE EUROPEAN MEDICINES AGENCY (PUB) |
coordinator | NL | LYGATURE | STICHTING LYGATURE (OTH) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | DE | Bayer | Bayer Pharma AG (PRC) |
participant | US | MIT | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (HES) |
participant | UK | PFIZER | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | DK | DHMA | SUNDHEDSSTYRELSEN (PUB) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | DK | Lundbeck | H. LUNDBECK AS (PRC) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
Within the project PRISM this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | NL | VUmc | STICHTING VUMC (REC) |
participant | NL | ECNP | STICHTING BURO ECNP (OTH) |
participant | NL | DTID | DRUG TARGET ID BV (PRC) |
participant | FR | BIOTRIAL | BIOTRIAL (PRC) |
participant | UK | SBG | SBGNEURO LTD (PRC) |
participant | UK | P1vital | P1VITAL LIMITED (PRC) |
participant | UK | Takeda EU | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | DE | concentris | Concentris Research Management GmbH (PRC) |
participant | BE | EUFAMI | EUROPESE FEDERATIE VAN FAMILIEVERENIGINGEN VAN PSYCHIATRISCH ZIEKE PERSONEN IVZW (OTH) |
participant | ES | CIBER | CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED M.P. (REC) |
participant | UK | ELI LILLY | Eli Lilly and Company Limited (PRC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
participant | UK | UNEXE | THE UNIVERSITY OF EXETER (HES) |
participant | NL | UMCU | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | NL | EMC | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
coordinator | NL | RUG | RIJKSUNIVERSITEIT GRONINGEN (HES) |
participant | NL | LUMC | ACADEMISCH ZIEKENHUIS LEIDEN (HES) |
participant | NL | RUMC | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
participant | IT | UNIBO | ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA (HES) |
Within the project PREFER this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | SPM | STEINBEISSER PROJECT MANAGEMENT UG (HAFTUNGSBESCHRANKT) (PRC) |
participant | DE | CSL | CSL BEHRING GMBH (PRC) |
participant | UK | MDUK | MUSCULAR DYSTROPHY GROUP OF GREAT BRITAIN AND NORTHERN IRELAND (OTH) |
participant | BE | MB | MINDBYTES (PRC) |
participant | UK | AbbVie | AbbVie Ltd (PRC) |
participant | UK | IAPO | INTERNATIONAL ALLIANCE OF PATIENT'ORGANIZATIONS (OTH) |
participant | UK | Amgen | AMGEN LIMITED (PRC) |
participant | BE | KCE | FEDERAAL KENNISCENTRUM VOOR DE GEZONDHEIDSZORG (REC) |
participant | UK | Takeda | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | BE | ECPC | EUROPEAN CANCER PATIENT COALITION (OTH) |
participant | IT | ITB | "INSTITUTO TUMORI ""GIOVANNI PAOLO II""" (REC) |
participant | NL | ASTELLAS | ASTELLAS PHARMA EUROPE BV (PRC) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | DE | Bayer | Bayer Pharma AG (PRC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SANOFI | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JP | JANSSEN PHARMACEUTICA NV (PRC) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
participant | CH | Actelion | ACTELION PHARMACEUTICALS LTD (PRC) |
participant | NL | ERASMUS | ERASMUS UNIVERSITEIT ROTTERDAM (HES) |
participant | DE | UKER | UNIVERSITATSKLINIKUM ERLANGEN (HES) |
participant | UK | UoB | THE UNIVERSITY OF BIRMINGHAM (HES) |
participant | NL | UMCU | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | IT | IEO | ISTITUTO EUROPEO DI ONCOLOGIA SRL (PRC) |
coordinator | SE | UU | UPPSALA UNIVERSITET (HES) |
participant | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | NL | EMC | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
participant | BE | KUL | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
Within the project PHAGO this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | AbbVie | ABBVIE DEUTSCHLAND GMBH & CO KG (PRC) |
participant | UK | Eisai | EISAI LIMITED (PRC) |
participant | DE | DZNE | DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV (REC) |
participant | DE | L&B | LIFE AND BRAIN GMBH (PRC) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | FR | SANOFI | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | IT | AXXAM | AXXAM SPA (PRC) |
participant | FI | ORION | ORION OYJ (PRC) |
participant | FR | ARTTIC | ARTTIC (PRC) |
coordinator | DE | UKB | UNIVERSITATSKLINIKUM BONN (HES) |
participant | DK | LUNDBECK | H. LUNDBECK AS (PRC) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | UK | UCL | UNIVERSITY COLLEGE LONDON (HES) |
participant | UK | UCAM | THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE (HES) |
participant | UK | KCL | KING'S COLLEGE LONDON (HES) |
participant | SE | UGOT | GOETEBORGS UNIVERSITET (HES) |
participant | DE | Fraunhofer | FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (REC) |
participant | DE | Charite | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
Within the project ROADMAP this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | NL | CBG/MEB | AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN (PUB) |
participant | UK | BIOGEN | BIOGEN IDEC LIMITED (PRC) |
participant | UK | IXICO | IXICO TECHNOLOGIES LIMITED (PRC) |
participant | UK | TAKEDA | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | CH | AC Immune | AC IMMUNE SA (PRC) |
participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | ES | IDIAP Jordi Gol | FUNDACIO INSTITUT UNIVERSITARI PERA LA RECERCA A L'ATENCIO PRIMARIA DE SALUT JORDI GOL I GURINA (REC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | LU | AE | ALZHEIMER EUROPE (OTH) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | FR | CHUB | CHU HOPITAUX DE BORDEAUX (HES) |
participant | UK | GE | GE HEALTHCARE LIMITED (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | UK | LSE | LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE (HES) |
participant | DK | Lundbeck | H. LUNDBECK AS (PRC) |
participant | UK | UEDIN | THE UNIVERSITY OF EDINBURGH (HES) |
participant | NL | UM | UNIVERSITEIT MAASTRICHT (HES) |
participant | SE | UGOT | GOETEBORGS UNIVERSITET (HES) |
coordinator | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
participant | NL | ERASMUS | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
participant | NL | RUG | RIJKSUNIVERSITEIT GRONINGEN (HES) |
participant | NL | LUMC | ACADEMISCH ZIEKENHUIS LEIDEN (HES) |
participant | DK | UCPH | KOBENHAVNS UNIVERSITET (HES) |
participant | DK | AU | AARHUS UNIVERSITET (HES) |
Within the project DO-IT this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | UK | HIQ | HEALTH IQ LIMITED (PRC) |
participant | UK | ABPI | THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY (OTH) |
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | SE | IHE | IHE, INSTITUTET FOR HALSO- OCH SJUKVARDSEKONOMI AKTIEBOLAG (PRC) |
participant | NO | NoMA | STATENS LEGEMIDDELVERK (PUB) |
participant | CH | Celgene | CELGENE MANAGEMENT SARL (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
participant | SE | TLV | TANDVARDS-OCH LAKEMEDELSFORMANSVERKET (PUB) |
participant | ES | FI | ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA (OTH) |
participant | DE | VFA | VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV (OTH) |
participant | BE | EMSP | THE EUROPEAN MULTIPLE SCLEROSIS PLATFORM AISBL (OTH) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | BE | ECPC | EUROPEAN CANCER PATIENT COALITION (OTH) |
participant | DE | TMF | TMF - TECHNOLOGIE UND METHODENPLATTFORM FUR DIE VERNETZTE MEDIZINISCHE FORSCHUNG EV (REC) |
participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
participant | BE | Amgen | AMGEN (PRC) |
participant | UK | ELI LILLY | Eli Lilly and Company Limited (PRC) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | DE | InterSystems | INTERSYSTEMS GMBH (PRC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | NO | NIPH | FOLKEHELSEINSTITUTTET (REC) |
participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
participant | IT | CERGAS | UNIVERSITA COMMERCIALE LUIGI BOCCONI (HES) |
participant | HU | SU | SEMMELWEIS EGYETEM (HES) |
coordinator | UK | LSE | LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo | NOVO NORDISK A/S (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | UK | ULIV | THE UNIVERSITY OF LIVERPOOL (HES) |
participant | UK | Imperial | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project ITCC-P4 this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | NL | PMC | PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV (OTH) |
participant | FR | ITCC | INNOVATIVE THERAPIES FOR CHILDREN WITH CANCER ASSOCIATION (REC) |
participant | FR | XenTech | XENTECH SAS (PRC) |
participant | DE | CR | CHARLES RIVER DISCOVERY RESEARCH SERVICES GERMANY GMBH (PRC) |
participant | DE | EPO | EXPERIMENTELLE PHARMAKOLOGIE UND ONKOLOGIE BERLIN-BUCH GMBH (PRC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | UK | PFIZER | PFIZER LIMITED (PRC) |
participant | AT | CCRI | ST. ANNA KINDERKREBSFORSCHUNG (REC) |
participant | NL | AMC | ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (HES) |
participant | FR | IGR | INSTITUT GUSTAVE ROUSSY (REC) |
participant | UK | ICR | THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (HES) |
participant | IT | ACC | ALLEANZA CONTRO IL CANCRO (OTH) |
participant | ES | FSJD | FUNDACIO SANT JOAN DE DEU (REC) |
participant | ES | PHARMAMAR | PHARMAMAR, S.A. (PRC) |
participant | FR | INSTITUT CURIE | INSTITUT CURIE (REC) |
participant | CH | UZH | UNIVERSITAT ZURICH (HES) |
participant | AT | MUW | MEDIZINISCHE UNIVERSITAET WIEN (HES) |
coordinator | DE | DKFZ | DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG (REC) |
participant | DE | CHARITE | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
Within the project EQIPD this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | BE | Arlenda | PHARMALEX BELGIUM (PRC) |
participant | US | SE | SCIENCE EXCHANGE, INC. (PRC) |
participant | BE | Arlenda | ARLENDA SA (PRC) |
participant | DE | PAASP | PAASP GMBH (PRC) |
participant | NL | ECNP | STICHTING BURO ECNP (OTH) |
participant | US | PGI | PSYCHOGENICS INC (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | US | ABBVIE | ABBVIE INC (PRC) |
participant | FR | Porsolt | PORSOLT SAS (PRC) |
participant | DE | UMC-Mainz | UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAET MAINZ (HES) |
participant | DE | concentris | Concentris Research Management GmbH (PRC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | NL | NOLDUS | NOLDUS INFORMATION TECHNOLOGY BV (PRC) |
participant | NL | Sylics | SYNAPTOLOGICS BV (PRC) |
participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
participant | FI | ORION | ORION OYJ (PRC) |
participant | UK | UniAbdn | THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN (HES) |
participant | FR | Servier | INSTITUT DE RECHERCHES SERVIER (PRC) |
coordinator | UK | UEDIN | THE UNIVERSITY OF EDINBURGH (HES) |
participant | CH | UBERN | UNIVERSITAET BERN (HES) |
participant | DE | LMU MUENCHEN | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (HES) |
participant | NL | RUG | RIJKSUNIVERSITEIT GRONINGEN (HES) |
participant | DE | EKUT | EBERHARD KARLS UNIVERSITAET TUEBINGEN (HES) |
participant | NL | RUMC | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
participant | DE | CHARITE | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
participant | UK | Imperial | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
Within the project eTRANSAFE this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | JP | Eisai | EISAI CO LTD (PRC) |
participant | UK | Clarivate | CLARIVATE ANALYTICS (UK) LIMITED (PRC) |
participant | UK | PDS | PDS COMPUTER SOFTWARE LIMITED (PRC) |
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | US | AbbVie | ABBVIE INC (PRC) |
participant | UK | OPTIBRIUM | OPTIBRIUM LIMITED (PRC) |
participant | FR | IPSEN | IPSEN INNOVATION SAS (PRC) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | UK | LL | LHASA LIMITED (REC) |
participant | DE | SANOFI | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
participant | DE | MN | MOLECULAR NETWORKS GMBH COMPUTERCHEMIE (PRC) |
participant | UK | LJMU | LIVERPOOL JOHN MOORES UNIVERSITY (HES) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | UK | SIMCYP | CERTARA UK LIMITED (PRC) |
coordinator | ES | IMIM | FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM (REC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | AT | UW-APRI | UNIVERSITAT WIEN (HES) |
participant | ES | UPF | UNIVERSIDAD POMPEU FABRA (HES) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | NL | ULEI | UNIVERSITEIT LEIDEN (HES) |
participant | DE | Fraunhofer | FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (REC) |
participant | DE | EMBL | EUROPEAN MOLECULAR BIOLOGY LABORATORY (REC) |
participant | NL | ERASMUS | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
Within the project MACUSTAR this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | ZEISS | CARL ZEISS MEDITEC AG (PRC) |
participant | DE | BAY | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | FR | ECRIN | ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK (REC) |
participant | FR | FVE | FONDATION DE COOPERATION SCIENTIFIQUE VOIR ET ENTENDRE (REC) |
participant | UK | MEH | MOORFIELDS EYE HOSPITAL NHS FOUNDATION TRUST (REC) |
participant | PT | AIBILI | AIBILI ASSOCIACAO PARA INVESTIGACAO BIOMEDICA E INNOVACAO EM LUZ E IMAGEM (REC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | UK | CITY | CITY UNIVERSITY OF LONDON (HES) |
coordinator | DE | UKB | UNIVERSITATSKLINIKUM BONN (HES) |
participant | UK | UCL | UNIVERSITY COLLEGE LONDON (HES) |
participant | UK | USFD | THE UNIVERSITY OF SHEFFIELD (HES) |
participant | NL | Radboudumc | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
Within the project PARADIGM this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | BE | Alexion | ALEXION SERVICES EUROPE SPRL (PRC) |
participant | CA | HTAi | HEALTH TECHNOLOGY ASSESSMENT INTERNATIONAL SOCIETY (OTH) |
participant | BE | Synergist | THE SYNERGIST (OTH) |
participant | UK | ABPI | THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY (OTH) |
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | IT | AIFA | AGENZIA ITALIANA DEL FARMACO (PRC) |
participant | UK | Amgen | AMGEN LIMITED (PRC) |
participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
participant | NL | STICHTING VU | STICHTING VU (HES) |
participant | DE | VFA | VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV (OTH) |
participant | FR | EURORDIS | EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION (OTH) |
participant | DE | GRT | GRUNENTHAL GMBH (PRC) |
participant | UK | Covance | COVANCE LABORATORIES LTD (PRC) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | LU | AE | ALZHEIMER EUROPE (OTH) |
participant | UK | PFIZER | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | ES | IACS | INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD (REC) |
participant | DE | EATG | EUROPEAN AIDS TREATMENT GROUP EV (OTH) |
coordinator | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | ES | FSJD | FUNDACIO SANT JOAN DE DEU (REC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | DK | Lundbeck | H. LUNDBECK AS (PRC) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | BE | EFGCP | EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE (OTH) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
Within the project c4c this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | HU | MCRN-Hungary | GYERMEKGYOGYASZATI KLINIKAI VIZSGALOI HALOZAT (OTH) |
participant | DE | HSK | HELIOS DR. HORST SCHMIDT KLINIKEN WIESBADEN GMBH (PRC) |
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | AT | OKIDS | OKIDS GMBH (OTH) |
participant | NL | ECAPN-ECNP | ECNP RESEARCH AND SCHOLARSHIP STICHTING (DE ECNP RESEARCH AND SCHOLARSHIP FOUNDATION) (OTH) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | DK | ECFS | EUROPEAN CYSTIC FIBROSIS SOCIETY (OTH) |
participant | FR | ECRIN | ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK (REC) |
participant | IT | FGB | FONDAZIONE PER LA RICERCA FARMACOLOGICA GIANNI BENZI ONLUS (REC) |
participant | CH | SCTO | SWISS CLINICAL TRIAL ORGANISATION (OTH) |
participant | FR | EURORDIS | EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION (OTH) |
participant | IT | ARSENAL | ARSENAL.IT - CENTRO VENETO RICERCAE INNOVAZIONE PER LA SANITA DIGITALE (REC) |
participant | ES | CHUS | SERVIZO GALEGO DE SAUDE (PUB) |
participant | NO | HUS-Norway | HELSE BERGEN HF*HAUKELAND UNIVERSITY HOSPITAL (HES) |
participant | PT | AIDFM | Associação para Investigação e Desenvolvimento da Faculdade de Medicina (HES) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | FR | SERVIER | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | BE | SIOPE | SIOP EUROPE ASBL (OTH) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SANOFI | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | DE | RBMF | ROBERT BOSCH GESELLSCHAFT FUR MEDIZINISCHE FORSCHUNG MBH (REC) |
participant | IT | OPBG | OSPEDALE PEDIATRICO BAMBINO GESU (OTH) |
participant | IT | IGG | ISTITUTO GIANNINA GASLINI (PUB) |
participant | FI | HUS | HELSINGIN JA UUDENMAAN SAIRAANHOITOPIIRIN KUNTAYHTYMÄ (REC) |
participant | PL | IPCZD | INSTYTUT POMNIK CENTRUM ZDROWIA DZIECKA (REC) |
coordinator | IT | PENTA | FONDAZIONE PENTA - FOR THE TREATMENT AND CARE OF CHILDREN WITH HIV ANDRELATED DISEASES - ONLUS (REC) |
participant | ES | FSJD | FUNDACIO SANT JOAN DE DEU (REC) |
participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
participant | DE | UKL-HD | UNIVERSITATSKLINIKUM HEIDELBERG (HES) |
participant | EE | UT | TARTU ULIKOOL (HES) |
participant | EL | AUTH | ARISTOTELIO PANEPISTIMIO THESSALONIKIS (HES) |
participant | CZ | CUNI | UNIVERZITA KARLOVA (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | UK | UCL | UNIVERSITY COLLEGE LONDON (HES) |
participant | IE | Tyndall - UCC | UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK (HES) |
participant | SE | KI | KAROLINSKA INSTITUTET (HES) |
participant | UK | UNILIV | THE UNIVERSITY OF LIVERPOOL (HES) |
participant | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | BE | UGent | UNIVERSITEIT GENT (HES) |
participant | NL | SKU | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project AIMS-2-TRIALS this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | US | SFARI | THE SIMONS FOUNDATION, INC (REC) |
participant | UK | Autistica | AUTISTICA (OTH) |
participant | ES | FPGF | FUNDAZIOA POLICLINICA GIPUZKOA FUNDACION (OTH) |
participant | IL | Teva | TEVA PHARMACEUTICAL INDUSTRIES LIMITED (PRC) |
participant | NL | ECNP | STICHTING BURO ECNP (OTH) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | US | AUTISM SPEAKS | AUTISM SPEAKS INC. NON PROFIT CORPORATION (OTH) |
participant | BE | AE | AUTISME-EUROPE AISBL (OTH) |
participant | FR | CHUT | CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE TOURS (HES) |
participant | BE | BIOSCI | BIOSCI CONSULTING BVBA (PRC) |
participant | PT | UCoimbra | UNIVERSIDADE DE COIMBRA (HES) |
participant | IT | FSM | Fondazione Stella Maris (REC) |
participant | NL | DEMCON | DEMCON ADVANCED MECHATRONICS ENSCHEDE B.V. (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | NL | NOLDUS | NOLDUS INFORMATION TECHNOLOGY BV (PRC) |
participant | ES | FCRB | FUNDACIO CLINIC PER A LA RECERCA BIOMEDICA (REC) |
participant | ES | SERMAS | SERVICIO MADRILENO DE SALUD (PUB) |
participant | DE | UMG-GOE | UNIVERSITAETSMEDIZIN GOETTINGEN - GEORG-AUGUST-UNIVERSITAET GOETTINGEN - STIFTUNG OEFFENTLICHEN RECHTS (HES) |
participant | FR | AP-HP | ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (REC) |
participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
participant | ES | STARLAB | STARLAB BARCELONA SL (PRC) |
participant | FR | ARTTIC | ARTTIC (PRC) |
participant | UK | BC | BIRKBECK COLLEGE - UNIVERSITY OF LONDON (HES) |
participant | IE | TCD | THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN (HES) |
participant | ES | USAL | UNIVERSIDAD DE SALAMANCA (HES) |
participant | DE | TUM-MED | KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN (HES) |
participant | ZA | SU | STELLENBOSCH UNIVERSITY (HES) |
participant | DE | UULM | UNIVERSITAET ULM (HES) |
participant | DE | CIMH | ZENTRALINSTITUT FUER SEELISCHE GESUNDHEIT (HES) |
participant | CH | UNIBAS | UNIVERSITAT BASEL (HES) |
participant | NL | UMCU | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | UK | UNIGLAS | UNIVERSITY OF GLASGOW (HES) |
participant | UK | UNI OF BRISTOL | UNIVERSITY OF BRISTOL (HES) |
participant | UK | UEDIN | THE UNIVERSITY OF EDINBURGH (HES) |
participant | UK | UCAM | THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE (HES) |
participant | SE | KI | KAROLINSKA INSTITUTET (HES) |
participant | DE | IAP | JOHANN WOLFGANG GOETHE-UNIVERSITATFRANKFURT AM MAIN (HES) |
coordinator | UK | KCL | KING'S COLLEGE LONDON (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
participant | SE | UU | UPPSALA UNIVERSITET (HES) |
participant | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | BE | UGENT | UNIVERSITEIT GENT (HES) |
participant | NL | RUG | RIJKSUNIVERSITEIT GRONINGEN (HES) |
participant | NL | RUMC | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
participant | FR | CEA | COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (REC) |
participant | FR | IPP | INSTITUT PASTEUR (REC) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project StarT this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | UK | NEWCELLS | NEWCELLS BIOTECH LIMITED (PRC) |
partner | IE | Fighting Blindness | Fighting Blindness (OTH) |
partner | NL | 20MED | 20MED THERAPEUTICS BV (PRC) |
participant | NL | ProQR | PROQR THERAPEUTICS NV (PRC) |
partner | CH | RETINA INTERNATIONAL | INTERNATIONAL RETINITIS PIGMENTOSA ASSOCIATION (OTH) |
participant | IT | FTELE.IGM | FONDAZIONE TELETHON (REC) |
partner | BE | EUROPEAN VISION INSTITUTE - EEIG | EUROPEAN VISION INSTITUTE - EEIG (REC) |
participant | IE | TCD | THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN (HES) |
participant | UK | ULEEDS | UNIVERSITY OF LEEDS (HES) |
participant | UK | UCL | UNIVERSITY COLLEGE LONDON (HES) |
coordinator | BE | UGent | UNIVERSITEIT GENT (HES) |
participant | ES | CSIC | AGENCIA ESTATAL CONSEJO SUPERIOR DEINVESTIGACIONES CIENTIFICAS (REC) |
participant | DE | EKUT | EBERHARD KARLS UNIVERSITAET TUEBINGEN (HES) |
participant | NL | RUMC | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
Within the project NEURONET this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | UK | PARKINSON'S UK | PARKINSON'S DISEASE SOCIETY OF THEUNITED KINGDOM LBG (OTH) |
participant | UK | TAKEDA | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
coordinator | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | LU | AE | ALZHEIMER EUROPE (OTH) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
Within the project TransBioLine this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | Signatope | SIGNATOPE GMBH (PRC) |
participant | LU | ITTM | INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE (ITTM) SA (PRC) |
participant | DE | METAHEPS | METAHEPS GMBH (PRC) |
participant | AT | TAM | TAMIRNA GMBH (PRC) |
participant | DE | MLM | MLM MEDICAL LABS GMBH (PRC) |
participant | DE | ABX CRO | ABX CRO ADVANCED PHARMACEUTICAL SERVICES FORSCHUNGSGESELLSCHAFT MBH (PRC) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | ES | SAS | SERVICIO ANDALUZ DE SALUD (PUB) |
participant | ES | IR-HSCSP | FUNDACIO PRIVADA INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU (REC) |
participant | FR | AP-HP | ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (REC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | IS | LANDSPITALI | LANDSPITALI UNIVERSITY HOSPITAL (HES) |
participant | ES | USAL | UNIVERSIDAD DE SALAMANCA (HES) |
participant | ES | UMA | UNIVERSIDAD DE MALAGA (HES) |
participant | NL | ULEI | UNIVERSITEIT LEIDEN (HES) |
coordinator | CH | UZH | UNIVERSITAT ZURICH (HES) |
participant | UK | UNOT | THE UNIVERSITY OF NOTTINGHAM (HES) |
participant | DE | LMU MUENCHEN | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (HES) |
participant | UK | ULIV | THE UNIVERSITY OF LIVERPOOL (HES) |
participant | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | DE | Charite | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
Within the project MIRIADE this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
coordinator | NL | STICHTING VUMC | STICHTING VUMC (REC) |
participant | BE | ADX | ADX NEUROSCIENCES (PRC) |
participant | NL | STICHTING VU | STICHTING VU (HES) |
participant | UK | LGC | LGC LIMITED (PRC) |
participant | FR | CHRUM | CENTRE HOSPITALIER UNIVERSITAIRE MONTPELLIER (OTH) |
participant | IT | UNIPG | UNIVERSITA DEGLI STUDI DI PERUGIA (HES) |
participant | LU | UL | UNIVERSITE DU LUXEMBOURG (HES) |
participant | DE | UULM | UNIVERSITAET ULM (HES) |
participant | SE | UGOT | GOETEBORGS UNIVERSITET (HES) |
participant | SE | KTH | KUNGLIGA TEKNISKA HOEGSKOLAN (HES) |
Within the project 3TR this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | IT | SIP Service | SIP SERVICE S.R.L. (PRC) |
participant | FR | SPLF | SOCIETE DE PNEUMOLOGIE DE LANGUE FRANCAISE (OTH) |
participant | NL | VUmc | STICHTING VUMC (REC) |
participant | UK | OWLSTONE | OWLSTONE MEDICAL LIMITED (PRC) |
participant | UK | LUPUS EUROPE | LUPUS EUROPE (OTH) |
participant | ES | ATRYS | ATRYS HEALTH, SA (PRC) |
participant | UK | Takeda | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | BE | UZGent | UNIVERSITAIR ZIEKENHUIS GENT (REC) |
participant | HR | GENOS | GENOS DOO ZA VJESTACENJE I ANALIZU (PRC) |
participant | DE | ALACRIS | ALACRIS THERANOSTICS GMBH (PRC) |
participant | DE | DRFZ | Deutsches Rheuma-Forschungszentrum Berlin (REC) |
participant | ES | CIBER | CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED M.P. (REC) |
participant | UK | ELF | EUROPEAN LUNG FOUNDATION (OTH) |
participant | BE | E.F.A. | EUROPEAN FEDERATION OF ASTHMA &ALLERGY ASSOCIATIONS IDEELL FORENING (OTH) |
participant | DE | SANOFI | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
coordinator | ES | FPS | FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD (REC) |
participant | NL | AMC | ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (HES) |
participant | BE | CUSL | CLINIQUES UNIVERSITAIRES SAINT-LUC (REC) |
participant | IT | AOUMEYER | AZIENDA OSPEDALIERO-UNIVERSITARIA ANNA MEYER (REC) |
participant | ES | SAS | SERVICIO ANDALUZ DE SALUD (PUB) |
participant | FR | CHU NANCY | CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE NANCY (HES) |
participant | CH | ERS | EUROPEAN RESPIRATORY SOCIETY (OTH) |
participant | ES | SUMMA | SERVICIO MADRILENO DE SALUD (PUB) |
participant | IT | IRCCS | FONDAZIONE IRCCS CA' GRANDA - OSPEDALE MAGGIORE POLICLINICO (OTH) |
participant | ES | CRG | FUNDACIO CENTRE DE REGULACIO GENOMICA (REC) |
participant | ES | IDIBAPS | CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (OTH) |
participant | SE | ORU | OREBRO UNIVERSITY (HES) |
participant | BE | VIB | VIB (REC) |
participant | DK | REGIONH | REGION HOVEDSTADEN (PUB) |
participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
participant | DE | EURICE | EURICE EUROPEAN RESEARCH AND PROJECT OFFICE GMBH (PRC) |
participant | PT | iMM | INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES (REC) |
participant | DE | CAU | CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL (HES) |
participant | IT | UNICA | UNIVERSITA DEGLI STUDI DI CAGLIARI (HES) |
participant | UK | QMUL | QUEEN MARY UNIVERSITY OF LONDON (HES) |
participant | DE | UMR | PHILIPPS UNIVERSITAET MARBURG (HES) |
participant | IT | UNIPI | UNIVERSITA DI PISA (HES) |
participant | IT | UNICT | UNIVERSITA DEGLI STUDI DI CATANIA (HES) |
participant | BE | UHASSELT | UNIVERSITEIT HASSELT (HES) |
participant | DE | MHH | MEDIZINISCHE HOCHSCHULE HANNOVER (HES) |
participant | PL | LODZ | UNIVERSYTET MEDYCZNY W LODZI. (HES) |
participant | IT | AOPD | AZIENDA OSPEDALE UNIVERSITA PADOVA (PUB) |
participant | DE | TUD | TECHNISCHE UNIVERSITAET DRESDEN (HES) |
participant | FR | UBO | UNIVERSITE DE BRETAGNE OCCIDENTALE (HES) |
participant | UK | UNIMAN | THE UNIVERSITY OF MANCHESTER (HES) |
participant | IT | UNIPMN | UNIVERSITA DEGLI STUDI DEL PIEMONTE ORIENTALE AMEDEO AVOGADRO (HES) |
participant | CH | UNIBAS | UNIVERSITAT BASEL (HES) |
participant | NL | UMCG | ACADEMISCH ZIEKENHUIS GRONINGEN (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | SE | AZ | ASTRAZENECA AB (PRC) |
participant | UK | UGLA | UNIVERSITY OF GLASGOW (HES) |
participant | IE | UCD | UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN (HES) |
participant | NO | UiB | UNIVERSITETET I BERGEN (HES) |
participant | UK | SOUTHAMPTON | UNIVERSITY OF SOUTHAMPTON (HES) |
participant | UK | UCL | UNIVERSITY COLLEGE LONDON (HES) |
participant | IT | UNIGE | UNIVERSITA DEGLI STUDI DI GENOVA (HES) |
participant | UK | UCAM | THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE (HES) |
participant | SE | KI | KAROLINSKA INSTITUTET (HES) |
participant | UK | ULEIC | UNIVERSITY OF LEICESTER (HES) |
participant | DE | MPL | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV (REC) |
participant | BE | KU Leuven | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
participant | ES | CSIC | AGENCIA ESTATAL CONSEJO SUPERIOR DEINVESTIGACIONES CIENTIFICAS (REC) |
participant | UK | QUB | THE QUEEN'S UNIVERSITY OF BELFAST (HES) |
participant | DE | CHARITE | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
participant | UK | Imperial | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project Immune-Image this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | NL | Lawrencium | LAWRENCIUM LEGAL BV (PRC) |
participant | US | ImaginAb | IMAGINAB, INC (PRC) |
participant | SE | Antaros | ANTAROS MEDICAL AB (PRC) |
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
coordinator | NL | VUmc | STICHTING VUMC (REC) |
participant | NL | TTOP | TTOPSTART BV (PRC) |
participant | UK | Takeda | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | BE | ECPC | EUROPEAN CANCER PATIENT COALITION (OTH) |
participant | ES | VHIO | FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON (REC) |
participant | NL | LYG | STICHTING LYGATURE (OTH) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | ES | VHIR | FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA (REC) |
participant | BE | VIB | VIB (REC) |
participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
participant | DE | WWU | WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER (HES) |
participant | BE | VUB | VRIJE UNIVERSITEIT BRUSSEL (HES) |
participant | NL | UMCG | ACADEMISCH ZIEKENHUIS GRONINGEN (HES) |
participant | UK | UCAM | THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE (HES) |
participant | DE | EKUT | EBERHARD KARLS UNIVERSITAET TUEBINGEN (HES) |
participant | FR | CEA | COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (REC) |
Within the project VIMS this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | PT | SCL | SERENITYCLOUD LDA (PRC) |
coordinator | ES | ALTRAN | ALTRAN INNOVACION SL (PRC) |
participant | ES | A-E | AIRBUS OPERATIONS SL (PRC) |
Within the project IDEA-FAST this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | UK | MBS | MEDIBIOSENSE LTD (PRC) |
participant | BE | BYTE | BYTEFLIES (PRC) |
participant | PT | FC.ID | FCIENCIAS.ID - ASSOCIACAO PARA A INVESTIGACAO E DESENVOLVIMENTO DE CIENCIAS (REC) |
participant | NL | MLCF | STICHTING MLC FOUNDATION (OTH) |
participant | IT | PLUR | PLURIBUS ONE SRL (PRC) |
participant | FR | DREEM | DREEM (PRC) |
participant | BE | EFCCA | EUROPEAN FEDERATION OF CROHN'S AND ULCERATIVE COLITIS ASSOCIATIONS (OTH) |
participant | FI | VTT | Teknologian tutkimuskeskus VTT Oy (REC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | FR | ECRIN | ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK (REC) |
participant | DE | GHI | GEORGE-HUNTINGTON-INSTITUT GMBH (PRC) |
participant | US | ABBV | ABBVIE INC (PRC) |
participant | UK | BIOGEN | BIOGEN IDEC LIMITED (PRC) |
participant | UK | PUK | PARKINSON'S DISEASE SOCIETY OF THEUNITED KINGDOM LBG (OTH) |
participant | FR | LIXOFT | LIXOFT SAS (PRC) |
participant | ES | APM | ASOCIACION PARKINSON MADRID (OTH) |
participant | NL | McR | MCROBERTS BV (PRC) |
participant | UK | TAK | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | DE | TMF | TMF - TECHNOLOGIE UND METHODENPLATTFORM FUR DIE VERNETZTE MEDIZINISCHE FORSCHUNG EV (REC) |
participant | UK | CCL | CAMBRIDGE COGNITION LIMITED (PRC) |
participant | NO | SUH | HELSE STAVANGER HF (OTH) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | UK | PFE | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | PL | IPIN | INSTYTUT PSYCHIATRII I NEUROLOGII (REC) |
participant | UK | IXS | IXSCIENT LIMITED (PRC) |
participant | FI | ORION | ORION OYJ (PRC) |
participant | DE | EMP | EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH (PRC) |
participant | IE | UL | UNIVERSITY OF LIMERICK (HES) |
participant | PT | IMM | INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES (REC) |
participant | DE | UKSH | UNIVERSITATSKLINIKUM SCHLESWIG-HOLSTEIN (HES) |
participant | UK | QMUL | QUEEN MARY UNIVERSITY OF LONDON (HES) |
participant | FR | IMT | INSTITUT MINES-TELECOM (HES) |
participant | AT | MUI | MEDIZINISCHE UNIVERSITAT INNSBRUCK (HES) |
participant | ES | UAM | UNIVERSIDAD AUTONOMA DE MADRID (HES) |
participant | IT | UNIBS | UNIVERSITA DEGLI STUDI DI BRESCIA (HES) |
participant | UK | UoM | THE UNIVERSITY OF MANCHESTER (HES) |
participant | SE | AZN | ASTRAZENECA AB (PRC) |
participant | UK | UGLAS | UNIVERSITY OF GLASGOW (HES) |
participant | UK | UCAM | THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE (HES) |
coordinator | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | NL | EMC | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
participant | NL | LUMC | ACADEMISCH ZIEKENHUIS LEIDEN (HES) |
participant | UK | ICL | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
Within the project PharmaLedger this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | PT | HES | HOSPITAL DO ESPIRITO SANTO DE EVORA EPE (PUB) |
participant | PT | INCM | IMPRENSA NACIONAL - CASA DA MOEDA, S. A. (PRC) |
participant | DE | BAYER | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | IL | AVO | ARTEEVO TECHNOLOGIES LTD (PRC) |
participant | US | ABBV | ABBVIE INC (PRC) |
participant | UK | TVS | TECHNOVATIVE SOLUTIONS LTD (PRC) |
participant | UK | ONO | ONORACH LTD (PRC) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | DE | UKW | UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT (HES) |
participant | UK | PFE | PFIZER LIMITED (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | EL | CERTH | ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS (REC) |
participant | IL | EKN | EKON MODELING SOFWARE SYSTEMS LTD*EKON (PRC) |
participant | IT | OPB | OSPEDALE PEDIATRICO BAMBINO GESU (OTH) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | RO | INCDTCI ICSI | NATIONAL RESEARCH AND DEVELOPMENT INSTITUTE FOR CRYOGENICS AND ISOTOPIC TECHNOLOGIES ICSI RM VALCEA (REC) |
participant | EL | DUT | DIMOKRITIO PANEPISTIMIO THRAKIS (HES) |
participant | PT | PDM | PDM E FC PROJECTO DESENVOLVIMENTO MANUTENCAO FORMACAO E CONSULTADORIALDA (PRC) |
participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
participant | RO | RMS | ROMSOFT SRL (PRC) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DK | NOVO | NOVO NORDISK A/S (PRC) |
participant | SE | AZN | ASTRAZENECA AB (PRC) |
participant | BE | EFGCP | EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE (OTH) |
coordinator | ES | UPM | UNIVERSIDAD POLITECNICA DE MADRID (HES) |
participant | BE | KU Leuven | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |